BTLA and autoimmune hepatitis: ◾ The expression of BTLA is decreased in MS (80) and SLE (81) patients, and increased in RA (87) patients.◾ Decreases susceptibility to EAE (4, 78), autoimmune hepatitis (79), and autoimmune diabetes (85, 86) in mice.